| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/03/2011 | US20110053840 Allele and isotope-specific intervention on mhc class ii molecules associated with autoimmune diseases by means of peptides |
| 03/03/2011 | US20110053839 GLP-1 Derivatives II |
| 03/03/2011 | US20110053827 Intranasal administration |
| 03/03/2011 | US20110052737 Topical skin formulations comprising botanical extracts |
| 03/03/2011 | US20110052736 Methods and materials for reducing or eliminating risk factors associated with syndrome x |
| 03/03/2011 | US20110052732 Mineral absorption accelerator and iron deficiency anemia improver of food composition |
| 03/03/2011 | US20110052729 Pharmaceutical or nutraceutical composition |
| 03/03/2011 | US20110052722 Toleration Iron Supplement Compositions |
| 03/03/2011 | US20110052707 Combination of vitamin d and 25-hydroxyvitamin d 3 |
| 03/03/2011 | US20110052694 Use of cannabidiol prodrugs in topical and transdermal administration with microneedles |
| 03/03/2011 | US20110052682 Methods for enhancing the release and absorption of water insoluble active agents |
| 03/03/2011 | US20110052669 Methods for modulating de novo hepatic lipogenesis by modulating xbp-1 activity |
| 03/03/2011 | US20110052643 Compounds for inflammation and immune-related uses |
| 03/03/2011 | US20110052625 Compositions and methods for treating diabetes using lisofylline analogs and islet neogenesis associated peptide |
| 03/03/2011 | US20110052621 Pcsk9 vaccine |
| 03/03/2011 | US20110052616 Biological materials and uses thereof |
| 03/03/2011 | US20110052612 Spiropiperidine compound and medicinal use thereof |
| 03/03/2011 | US20110052585 Compositions and methods for inhibiting interleukin pathways |
| 03/03/2011 | US20110052569 Molecules and methods for treatment of diabetes |
| 03/03/2011 | US20110052562 Benzimidazoles and analogs as rho kinase inhibitors |
| 03/03/2011 | US20110052559 Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency |
| 03/03/2011 | US20110052554 Methods for off-the- shelf tumor immunotherapy using allogeneic t-cell precursors |
| 03/03/2011 | US20110052538 Probiotic/non-probiotic combinations |
| 03/03/2011 | US20110052527 Imidazopyridinyl thiazolyl histone deacetylase inhibitors |
| 03/03/2011 | US20110048980 Fatty Acid Oxidation Inhibitors Treating Hyperglycemia and Related Disorders |
| 03/03/2011 | DE102009038210A1 Medicament, useful e.g. for treating diabetes, controlling fasting, postprandial or postabsorptive blood glucose concentration in diabetic patients and improving glucose tolerance, comprises insulin and glucagon-like peptide-1 agonist |
| 03/03/2011 | CA2790390A1 Novel tetrahydroisoquinoline compounds |
| 03/03/2011 | CA2773133A1 Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency |
| 03/03/2011 | CA2772441A1 Use of a holotoxin to reduce endoplasmic reticulum-associated degradation of misfolded proteins |
| 03/03/2011 | CA2772093A1 Np-1 antagonists and their therapeutic use |
| 03/03/2011 | CA2769151A1 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors |
| 03/02/2011 | EP2289970A1 Biocompatible polymers, their process of manufacture and compositions containing them |
| 03/02/2011 | EP2289908A1 Use of DG177 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 03/02/2011 | EP2289894A2 Pyrrolo-triazine compounds useful as kinase inhibitors |
| 03/02/2011 | EP2289893A1 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 03/02/2011 | EP2289883A1 Novel FXR (NR1H4) binding and activity modulating compounds |
| 03/02/2011 | EP2289560A2 Polypeptide protracting tags comprising a tetrazole moiety |
| 03/02/2011 | EP2289556A2 Pharmaceutical composition for use in treatment of diabetes |
| 03/02/2011 | EP2289551A1 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/02/2011 | EP2289539A1 Zinc-free and low-zinc insulin preparations with improved stability |
| 03/02/2011 | EP2289531A2 Medicaments for increasing endogenous erythropoietine (EPO) |
| 03/02/2011 | EP2289513A2 Method for decreasing the blood glucose level in mammals |
| 03/02/2011 | EP2289510A1 Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
| 03/02/2011 | EP2289509A2 Methods for purifying trans-(-)-delta9-tetrahydrocannabinol and trans-(+)-delta9-tetrahydrocannabinol |
| 03/02/2011 | EP2289503A2 Treating muscle wasting with selective androgen receptor modulators |
| 03/02/2011 | EP2289502A1 Combination comprising S-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]2-methylpropanethioate and an HMG CoA reductase inhibitor |
| 03/02/2011 | EP2289501A1 Combination comprising S-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]2-methylpropanethioate and an HMG CoA reductase inhibitor |
| 03/02/2011 | EP2288607A1 Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| 03/02/2011 | EP2288605A1 Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| 03/02/2011 | EP2288604A1 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| 03/02/2011 | EP2288603A1 Tetrazole compounds as orexin receptor antagonists |
| 03/02/2011 | EP2288596A2 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use |
| 03/02/2011 | EP2288594A1 Imidazolidine derivatives |
| 03/02/2011 | EP2288364A1 Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances |
| 03/02/2011 | EP2035417B1 Benzimidazoles and their use for the treatemnt of diabetes |
| 03/02/2011 | EP1957479B1 1,5-substituted indol-2-yl amide derivatives |
| 03/02/2011 | EP1261427B1 Microfabricated devices and methods for storage and selective exposure of chemicals |
| 03/02/2011 | CN1927888B Recombination albumen of GLP-1 and analogue thereof and human lysozyme fusion and application thereof |
| 03/02/2011 | CN1568195B Peptide YY and peptide YY agonists for treatment of metabolic disorders |
| 03/02/2011 | CN101983073A Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation |
| 03/02/2011 | CN101983072A Mineral absorption accelerator and iron deficiency anemia improver or food composition |
| 03/02/2011 | CN101983065A Agents for promoting secretion and/or suppressing decrease of adiponectin |
| 03/02/2011 | CN101983064A Absorbent ingestible agents and associated methods of manufacture and use |
| 03/02/2011 | CN101983062A Abca-1 elevating compounds and the use thereof |
| 03/02/2011 | CN101982465A Flavonoid compound extracted from liquorice and preparation method and application thereof |
| 03/02/2011 | CN101982458A 3-amino-3-arylpropionic acid and preparation method thereof |
| 03/02/2011 | CN101982200A Rhizoma coptidis total alkaloids resin complexes, sustained-release preparation thereof and preparation method thereof |
| 03/02/2011 | CN101982197A Plukenetia volubilis polypeptide oral liquid |
| 03/02/2011 | CN101982194A Coptis root compound preparation for treating dampness-heat spleen encumbering type diabetes |
| 03/02/2011 | CN101982191A Method for extracting fat-reducing compound functional materials from lotus leaves |
| 03/02/2011 | CN101982176A Compound sodium selenite-vitamin E oral nano-emulsion preparation for livestock and preparation method thereof |
| 03/02/2011 | CN101413012B Method for inducing differentiation of mesenchyma stem cell into islet beta-like cells, and use thereof |
| 03/02/2011 | CN101366829B Method for synchronously extracting flavone and alkaloid from folium nelumbinis |
| 03/02/2011 | CN101193656B Novel triglyceride reducing agent |
| 03/02/2011 | CA2714374A1 Weight loss composition and method |
| 03/01/2011 | US7897757 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 03/01/2011 | US7897644 Antiinflammatory agents; analgesics |
| 03/01/2011 | US7897628 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase |
| 03/01/2011 | US7897618 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/01/2011 | US7897615 Cyanoamide compounds useful as malonyl-CoA decarboxylase inhibitors |
| 03/01/2011 | US7897595 Pyridoazepine derivatives |
| 03/01/2011 | US7897560 Plasma protein affinity tags |
| 03/01/2011 | US7897384 Chondrocyte therapeutic delivery system |
| 03/01/2011 | US7897180 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 03/01/2011 | CA2602348C Cyclopentapyridine and tetrahydroquinoline derivatives |
| 03/01/2011 | CA2437240C Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof |
| 03/01/2011 | CA2423335C Spray drying process and compositions of fenofibrate |
| 03/01/2011 | CA2396590C 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 02/24/2011 | WO2011022394A2 Materials and methods for the development of an antigen-specific immune non-responsiveness state |
| 02/24/2011 | WO2011022393A2 Phosphatidylcholine transfer protein inhibitors |
| 02/24/2011 | WO2011022334A1 Use of nkg2d inhibitors for treating cardiovascular and metabolic diseases, such as type 2 diabetes |
| 02/24/2011 | WO2011022056A2 PEPTIDE MODULATORS OF THE δPKC INTERACTION WITH THE D SUBUNIT OF F1FO ATP SYNTHASE/ATPASE AND USES THEREOF |
| 02/24/2011 | WO2011022045A2 Apparatus and process for generating and harvesting adult stem cells and fluid associated with it from skin and omentum for medical, cosmetic, and veterinary use |
| 02/24/2011 | WO2011021678A1 Fused heterocyclic compound |
| 02/24/2011 | WO2011021645A1 Bicyclic urea derivative or pharmacologically permitted salt thereof |
| 02/24/2011 | WO2011021524A1 Peptides inducing adhesive property of lactic acid bacterium and use of same |
| 02/24/2011 | WO2011021203A2 Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| 02/24/2011 | WO2011020853A1 Compositions containing mixtures of fermentable fibers |
| 02/24/2011 | WO2011020615A1 Novel fxr (nr1h4 ) binding and activity modulating compounds |
| 02/24/2011 | WO2011020320A1 Homodimer of insulinotropic peptide analogues and method for preparation thereof and use thereof |